News | Breast Biopsy Systems | May 08, 2018

New Analytics Approach Offers Potential of Reducing Unnecessary Breast Biopsies

Study defines advanced statistical methods that can be used with diagnostic imaging output to downgrade breast mass risk classification

New Analytics Approach Offers Potential of Reducing Unnecessary Breast Biopsies

May 8, 2018 — The American Journal of Roentgenology recently published findings on statistical methods for downgrading the risk classification of breast masses to reduce the need for unnecessary breast biopsies. Clinicians from Seno Medical and medical center collaborators from The University of Texas co-authored the report.1  

"The perceived risk of missing a breast cancer diagnosis with breast imaging studies is much higher than the risk of a false-positive diagnosis, leading to breast imagers recommending a breast biopsy whenever the risk of cancer is greater than 2 percent. Sometimes ancillary diagnostic breast imaging studies are performed to reduce risk to less than 2 percent, but it is difficult to know exactly how much risks are reduced even after a negative ancillary diagnostic imaging examination," said Thomas Stavros, M.D., chief medical officer of Seno Medical and a co-author of the report. "However, the use of the Negative Likelihood Ratio (NLR) along with BI-RADS [Breast Imaging-Reporting and Data System] 4 subcategories can help to reduce the number of false-positives without experiencing excessive negative results that would lead to cancer going undiagnosed."

The report explores the use of a statistical calculation known as the Negative Likelihood Ratio (NLR). It shows how NLR can be calculated from a diagnostic test's sensitivity and specificity and also show the NLRs of some currently available diagnostic imaging modalities. It outlines how the BI-RADS 4A sub-category has low enough and narrow enough range of pre-test probabilities (see Table 1) to allow downgrading to a post-test probability of 2 percent or less after a negative diagnostic imaging test with an adequately low NLR.

 

FINAL ASSESSMENT CATEGORIES

Category

Management

Likelihood of cancer

0

Need Additional Imaging or Prior Examinations

Recall for Additional Imaging and/or Await Prior Examinations

n/a

1

Negative

Routine Screening

Essentially 0%

2

Benign

Routing Screening

Essentially 0%

3

Probably Benign

Short Interval Follow-up (6 month) or Continued

>0% but < 2%

4

Suspicious

Tissue Diagnosis

  • 4a. low suspicion for malignancy (>2% to < 10%)
  • 4b. moderate suspicion for malignancy (>10% to < 50%)
  • 4c. high suspicion for malignancy (>50% to <95%)

5

Highly Suggestive of Malignancy

Tissue Diagnosis

>95%

6

Known Biopsy-Proven

Surgical Excision when Clinically Appropriate

n/a

Table 1. BI-RADS Categories

Source: http://www.radiologyassistant.nl/data/bin/a53b4293920e94_TAB-Birads

"Reducing the number of unnecessary breast biopsies is an essential advancement toward improving women's healthcare and protecting breast health," said Pam Otto, M.D., Department of Radiology, The University of Texas Health Science Center at San Antonio and co-author. "I would encourage breast imagers to consider using BI-RADS 4 subcategories and NLR as important tools for helping them minimize false positive studies with minimum adverse effect on sensitivity, optimizing their patients' breast health. The availability of web-based programs for automating the NLR calculations should help to facilitate routine use of this important statistical tool."

For more information: www.ajronline.org

References

1. Yang WT, Parikh JR, Stavros AT, Otto P and Maislin G. Exploring the Negative Likelihood Ratio and How It Can Be Used to Minimize False-Positives in Breast Imaging. AJR 2018;210:301-306.

 

 

Related Content

iCAD Announces Positive Clinical Results for Artificial Intelligence Tomosynthesis Technology
News | Mammography | October 11, 2018
iCAD Inc. announced positive clinical results of its new digital breast tomosynthesis (DBT) cancer detection software,...
"Where's My Mammogram?" Campaign Helps Women Own Breast Health Records
News | Breast Imaging | October 10, 2018
October 10, 2018 — Mammosphere launched “Where’s My Mammogram?,” a public service campaign to help women obtain copie
DenseBreast-info.org Launches European Expansion
News | Breast Density | October 10, 2018
DenseBreast-info.org (DB-I) announced the launch of its international expansion for European medical providers. The...
X-ray Mammography Adoption to Skyrocket for Breast Cancer Detection
News | Mammography | October 08, 2018
Highly populated countries have traditionally been slow adopters of non-conventional business models, but a new Frost...
Cullman Regional Medical Center

Cullman Regional Medical Center (Alabama) is a 145-bed medical center serving more than 175,000 residents in a six-county area and recognized as one of the region’s finest medical facilities.

Sponsored Content | Case Study | PACS | October 05, 2018
When Cullman Regional Medical Center in Alabama decided to switch from 2-D
Feature | Mammography | October 05, 2018 | By Jeff Zagoudis
“Patient-centered care” is a popular term among those in the healthcare industry in the 21st century. It means the...
Feature | Breast Imaging | October 04, 2018 | By Tracy Accardi
It has been nearly eight years since the world’s first digital breast tomosynthesis (DBT) mammography technology was...
Leica Biosystems Launches MammoPort Specimen Containment and Transport System
Technology | Breast Biopsy Systems | October 03, 2018
Leica Biosystems announced the U.S. launch of MammoPort, the first integrated specimen containment and transport system...
Xoft Electronic Brachytherapy System Effective Long-Term for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 02, 2018
Breast cancer recurrence rates for patients treated with the Xoft Axxent Electronic Brachytherapy (eBx) System that...
Survey Shows Dense Breast Reporting Laws Increase Breast Density Awareness
News | Breast Density | October 02, 2018
October 2, 2018 — Results from a new study show that...